{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T00:16:32Z","timestamp":1703981792675},"reference-count":18,"publisher":"Japan Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1507\/endocrj.ej23-0125","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T22:57:43Z","timestamp":1695682663000},"page":"1187-1193","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetes"],"prefix":"10.1507","volume":"70","author":[{"given":"Eijiro","family":"Yamada","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyo","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Horiguchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Holt RIG, DeVries JH, Hess-Fischl A, Hirsch IB, Kirkman MS, et al. (2021) The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 64: 2609\u20132652.","DOI":"10.1007\/s00125-021-05568-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, et al. (2017) Continuous glucose monitoring <i>vs.<\/i> conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: The GOLD Randomized Clinical Trial. JAMA 317: 379\u2013387. Erratum in: <i>JAMA<\/i> 317: 1912.","DOI":"10.1001\/jama.2016.19976"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3 Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kr\u00f6ger J, Weitgasser R (2016) Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet 388: 2254\u20132263.","DOI":"10.1016\/S0140-6736(16)31535-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Parkin CG, Graham C, Smolskis J (2017) Continuous glucose monitoring use in type 1 diabetes: longitudinal analysis demonstrates meaningful improvements in HbA1c and reductions in health care utilization. J Diabetes Sci Technol 11: 522\u2013528.","DOI":"10.1177\/1932296817693253"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Charleer S, De Block C, Van Huffel L, Broos B, Fieuws S, et al. (2020) Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE): a prospective observational real-world cohort study. Diabetes Care 43: 389\u2013397.","DOI":"10.2337\/dc19-1610"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6 Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, et al. (2019) Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care 42: 1593\u20131603.","DOI":"10.2337\/dci19-0028"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Vigersky R, Shrivastav M (2017) Role of continuous glucose monitoring for type 2 in diabetes management and research. J Diabetes Complications 31: 280\u2013287.","DOI":"10.1016\/j.jdiacomp.2016.10.007"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 American Diabetes Association Professional Practice Committee (2022) 7. Diabetes technology: standards of medical care in diabetes-2022. Diabetes Care 45(Suppl 1): S97\u2013S112.","DOI":"10.2337\/dc22-S007"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Adolfsson P, Parkin CG, Thomas A, Krinelke LG (2018) Selecting the appropriate continuous glucose monitoring system\u2014a practical approach. Eur Endocrinol 14: 24\u201329.","DOI":"10.17925\/EE.2018.14.1.24"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Visser MM, Charleer S, Fieuws S, De Block C, Hilbrands R, et al. (2021) Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial. Lancet 397: 2275\u20132283.","DOI":"10.1016\/S0140-6736(21)00789-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Brown RE, Chu L, Norman GJ, Abitbol A (2022) Real-world glycaemic outcomes in adult persons with type 1 diabetes using a real-time continuous glucose monitor compared to an intermittently scanned glucose monitor: a retrospective observational study from the Canadian LMC diabetes registry (REAL-CGM-T1D). Diabet Med 39: e14937.","DOI":"10.1111\/dme.14937"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Pr\u00e9au Y, Armand M, Galie S, Schaepelynck P, Raccah D (2021) Impact of switching from intermittently scanned to real-time continuous glucose monitoring systems in a type 1 diabetes patient French cohort: an observational study of clinical practices. Diabetes Technol Ther 23: 259\u2013267.","DOI":"10.1089\/dia.2020.0515"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Xing D, Kollman C, Beck RW, Tamborlane WV, Laffel L, et al. (2011) Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring. Diabetes Technol Ther 13: 351\u2013358.","DOI":"10.1089\/dia.2010.0156"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Bailey T, Bode BW, Christiansen MP, Klaff LJ, Alva S (2015) The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther 17: 787\u2013794.","DOI":"10.1089\/dia.2014.0378"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Foster NC, Miller KM, Tamborlane WV, Bergenstal RM, Beck RW, et al. (2016) Continuous glucose monitoring in patients with type 1 diabetes using insulin injections. Diabetes Care 39: e81\u2013e82.","DOI":"10.2337\/dc16-0207"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Champakanath A, Akturk HK, Alonso GT, Snell-Bergeon JK, Shah VN (2022) Continuous glucose monitoring initiation within first year of type 1 diabetes diagnosis is associated with improved glycemic outcomes: 7-year follow-up study. Diabetes Care 45: 750\u2013753.","DOI":"10.2337\/dc21-2004"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Mulinacci G, Alonso GT, Snell-Bergeon JK, Shah VN (2019) Glycemic outcomes with early initiation of continuous glucose monitoring system in recently diagnosed patients with type 1 diabetes. Diabetes Technol Ther 21: 6\u201310.","DOI":"10.1089\/dia.2018.0257"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Nguyen A, White JR (2022) FreeStyle Libre 3. Clin Diabetes 41: 127\u2013128.","DOI":"10.2337\/cd22-0102"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/12\/70_EJ23-0125\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T04:06:06Z","timestamp":1703909166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/12\/70_EJ23-0125\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej23-0125","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"EJ23-0125"}}